PBMs have evaded lawmakers’ reform attempts so far. Could 2025 turn the tide?
PharmaVoice
JANUARY 6, 2025
How regulators could hit PBMs from multiple sides in the coming year.
Sat.Jan 04, 2025 - Fri.Jan 10, 2025
130 
Amgen’s lung cancer treatment gets conditional approval
PharmaTimes
JANUARY 6, 2025
IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer
What AI Can Do for Pharmacist Burnout
MedCity News
JANUARY 9, 2025
AI offers a number of immediate opportunities for pharmacies to change their operation through intelligent automation, freeing up pharmacists to provide their patient population with higher-value services like patient counseling and medication management. The post What AI Can Do for Pharmacist Burnout appeared first on MedCity News.
FDA issues first recommendations on AI for drug development
European Pharmaceutical Review
JANUARY 7, 2025
The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.
5 Ways You Can Win Faster with Gen AI in Sales
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win
PharmaVoice
JANUARY 9, 2025
Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.
FDA CDER director Patrizia Cavazzoni announces resignation
Pharmaceutical Technology
JANUARY 10, 2025
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Goals of the Association for Prescription Psychedelics
Pharmaceutical Commerce
JANUARY 6, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), provides a peek into what the association has set out to accomplish.
3 trial readouts that could shake up the obesity market this year
PharmaVoice
JANUARY 8, 2025
A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.
FDA issues first guidance on AI in medicine development
pharmaphorum
JANUARY 7, 2025
The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area
Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship’s Valo Health
MedCity News
JANUARY 8, 2025
Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagships Valo Health appeared first on MedCity News.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
AI and Content — The 2024 Trend that Wasn’t and the Related Opportunity that Exists
Copyright Clearance Center
JANUARY 9, 2025
As a result of EU law and other factors, rights holders are reserving their AI rights. This material is available for AI training/licensing.
NICE recommends olaparib for BRCA-mutated breast cancer treatment
PharmaTimes
JANUARY 9, 2025
Groundbreaking approval provides new hope for patients in England and Wales
Verona says COPD drug is off to a flying start
pharmaphorum
JANUARY 7, 2025
Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.
Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More
MedCity News
JANUARY 8, 2025
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO markets return to normal levels. The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on MedCity News.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Building a Voice for Psychedelic Research
Pharmaceutical Commerce
JANUARY 7, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), explains why this resource is an asset, specifically for research in the psychedelic space.
New prostate cancer test cuts biopsies by 50% in US
PharmaTimes
JANUARY 6, 2025
EpiSwitch PSE shows promise in reducing unnecessary procedures
AMD shadows NVIDIA with a move into AI drug discovery
pharmaphorum
JANUARY 9, 2025
Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.
Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B
MedCity News
JANUARY 8, 2025
Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagoss headcount by 40%. The post Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by 2.4B appeared first on MedCity News.
4 closely-watched FDA approval dates in 2025 from Vertex, Novo, J&J and more
PharmaVoice
JANUARY 6, 2025
A first-in-class pain med and blockbusters with new indications are just a few of the possible approvals to keep an eye on in the new year.
Angelini Ventures co-leads Series A financing in Neumirna Therapeutics
PharmaTimes
JANUARY 8, 2025
Investment to support RNA therapeutics for epilepsy and neurological disorders
Verdiva Bio raises $411m for obesity pipeline
pharmaphorum
JANUARY 9, 2025
A new obesity start-up Verdiva Bio has just decloaked with a whopping $411m to advance a once-weekly oral GLP-1 agonist.
What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations
MedCity News
JANUARY 8, 2025
When it comes to managing inbound phone calls, underperformance has devastating cost implications. The post What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations appeared first on MedCity News.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Cavazzoni Retires as CDER Director
PharmaTech
JANUARY 10, 2025
Patrizia Cavazzoni, director of FDAs Center for Drug Evaluation and Research, has announced her retirement from the agency.
New therapy hope for prostate cancer patients
PharmaTimes
JANUARY 9, 2025
CR-discovered NXP800 shows promise in clinical trials
MSD buys Irish vaccines plant from WuXi for €500m
pharmaphorum
JANUARY 6, 2025
MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk.
Study: Why Quick Fixes Don’t Work in Workplace Wellness
MedCity News
JANUARY 8, 2025
By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits. The post Study: Why Quick Fixes Dont Work in Workplace Wellness appeared first on MedCity News.
10 Ways to Leverage Buyer Signals and Drive Revenue
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Variant Bio and Novo Nordisk to identify targets for metabolic disease treatment
Pharmaceutical Technology
JANUARY 7, 2025
Variant has entered a multi-year research partnership with Novo Nordisk to identify new targets to treat metabolic conditions.
Novartis gene therapy set to enhance SMA treatment
PharmaTimes
JANUARY 7, 2025
OAV101 IT expands potential for type II SMA patients
US reports its first fatal case of H5N1 bird flu
pharmaphorum
JANUARY 7, 2025
A man in Louisiana has become the first recorded fatality in the US attributed to the H5N1 strain of bird flu.
Accolade Gets a Do-Over With Transcarent’s $621M Acquisition
MedCity News
JANUARY 8, 2025
Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say. The post Accolade Gets a Do-Over With Transcarent’s $621M Acquisition appeared first on MedCity News.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Let's personalize your content